Proposal to list medical devices supplied by Medix 21 Limited
Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by Medix 21 Limited in Part III of Section H of the Pharmaceutical Schedule from 1 November 2022 in the following category:
Consultation closes at 4pm Tuesday 30 August 2022 and feedback can be emailed to firstname.lastname@example.org.
What would the effect be?
From 1 November 2022, Medix 21’s range of medical devices in the surgical implants, medical and surgical instruments and power tools categories would be listed under a national agreement for all Te Whatu Ora Hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreement”).
The Agreement would not be for sole supply, with Te Whatu Ora Hospitals continuing to be able to purchase other suppliers’ brands of surgical implants, medical and surgical instruments and power tools.
The Agreement would supersede any existing Te Whatu Ora Hospital contracts with this supplier for the medical devices listed in Schedule 1 in the Agreement. Any device listed in the Pharmac Agreement and purchased by a Te Whatu Ora Hospital would be at the price, terms and conditions stated in the Agreement, effective from the date of listing on the Pharmaceutical Schedule.
As part of the Agreement, Medix 21 would provide appropriate training and education services that would be tailored to the needs of the individuals Te Whatu Ora Hospitals, in formats and at times as required by Te Whatu Ora Hospitals.
Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Te Whatu Ora Hospital staff including but not limited to:
- Perioperative staff
- ICU, emergency, and critical care staff
- Surgical and general ward staff
- Ambulatory care staff
- Clinical engineers and maintenance services
- Sterile services personnel
- Procurement and supply chain personnel
- Suppliers and wholesalers
About the medical devices
Medical and surgical instruments, and surgical implants
Medical and surgical instruments and power tool products are used in a vast range of surgical and medical specialities and procedures. Some are more generally used within clinical practice and others have highly specific applications. Some require power sources or other equipment to perform their function.
Surgical implants are devices that are placed in or on the body. These devices support a range of functions, such as replacing damaged tissue, supporting existing tissue or enhancing existing bodily functions. Surgical implants as a group encompass a range of products, including reconstructive implants, surgical stents, orthopaedic soft tissue fixation, surgical mesh, ocular implants, aural implants and implantable neurostimulators.
Why we’re proposing this
In 2021 Pharmac issued a Request for Proposals (“RFP”) for the supply of surgical implants, medical and surgical instruments and power tools, and associated products.
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFP to seek provisional agreements and this is the first proposal to arise from this process.
Details about our proposal
The proposal would result in 2178 medical devices being listed in the Pharmaceutical Schedule covering the following ranges:
- Handicare/System RoMedic
- Madhu Instruments
- New World Medical
- Spiggle & Theis
Further information, including pricing and contractual details, has been provided to Te Whatu Ora procurement personnel. Clinicians interested in further detail on what this change means for their hospital should engage with their procurement teams.
To provide feedback
Send us an email: email@example.com by 4pm 30 August 2022.
All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.